Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #536814 on NorthWest Biotherapeutics Inc (NWBO)
hoffmann6383
11/21/22 1:42 PM
#536818 RE: dr_lowenstein #536814
hope4patients
11/21/22 1:44 PM
#536820 RE: dr_lowenstein #536814
SkyLimit2022
11/21/22 1:58 PM
#536826 RE: dr_lowenstein #536814
"This is the first time in 20 years that a phase III trial showed extended survival for stage 3 glioblastoma patients," said Julian K. Wu, MD, co-author of a new study in JAMA Oncology. Read more: https://t.co/dihDPOxYbP#TuftsMedicine @TuftsMCResearch @TuftsMedSchool pic.twitter.com/4oDCzq6rbJ— Tufts Medical Center (@TuftsMedicalCtr) November 17, 2022
"This is the first time in 20 years that a phase III trial showed extended survival for stage 3 glioblastoma patients," said Julian K. Wu, MD, co-author of a new study in JAMA Oncology. Read more: https://t.co/dihDPOxYbP#TuftsMedicine @TuftsMCResearch @TuftsMedSchool pic.twitter.com/4oDCzq6rbJ